Increased expression and activation of IL-12-induced Stat4 signaling in the mucosa of ulcerative colitis patients

Cellular Immunology

Volumn 248, Issue 2, 2007, Pages 115-120

  Pang, Yan Hua ^a   Zheng, Chang Qing ^b   Yang, Xian Zi ^c   Zhang, Wen Jie ^d  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b CHINA MEDICAL UNIVERSITY   (China)

^c HUBEI UNIVERSITY OF MEDICINE   (China)

^d HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

IBD; IFN ; IL 12; IL 23; Stat4; Th1; Th17; Th2; Ulcerative colitis

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 12; STAT4 PROTEIN;

ADULT; AGED; ARTICLE; CELL NUCLEUS; CHINESE; CLINICAL ARTICLE; COLON MUCOSA; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOPLASM; DISEASE ACTIVITY; FEMALE; HUMAN; HUMAN TISSUE; MALE; MUCOSA CELL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; ULCERATIVE COLITIS; WESTERN BLOTTING;

ADULT; AGED; COLITIS, ULCERATIVE; FEMALE; HUMANS; INTERLEUKIN-12 SUBUNIT P40; INTESTINAL MUCOSA; MALE; MIDDLE AGED; SIGNAL TRANSDUCTION; STAT4 TRANSCRIPTION FACTOR; UP-REGULATION;

EID: 37349050665     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2007.10.003     Document Type: Article

References (33)

1. In: Targan R., and Shanahan F. (Eds). Inflammatory Bowel Disease: From Bench to Bedside (1994), Williams and Wilkins, Baltimore
2. Fiocchi C. Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology 115 (1998) 182-205
3. Zhang W.J., and Koltun W.A. Genetic factors in the etiology and potential management of IBD. Semin. Colon. Rectal. Surg. 12 (2001) 2-8
4. Duerr R.H., Taylor K.D., Brant S.R., Rioux J.D., Silverberg M.S., Daly M.J., et al. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 314 (2006) 1461-1463
5. Guo Q.S., Xia B., Jiang Y., Qu Y., and Li J. NOD2 3020insC frameshift mutation is not associated with inflammatory bowel disease in Chinese patients of Han nationality. World J. Gastroenterol. 10 (2004) 1069-1071
6. Inoue N., Tamura K., Kinouchi Y., Fukuda Y., Takahashi S., Ogura Y., et al. Lack of common NOD2 variants in Japanese patients with Crohn's disease. Gastroenterology 123 (2002) 86-91
7. Jiang X.L., and Cui H.F. An analysis of 10218 ulcerative colitis cases in China. World J. Gastroenterol. 8 (2002) 158-161
8. Hanauer S.B. Inflammatory bowel disease: epidemiology, pathegenesis, and therapeutic opportunities. Inflamm. Bowel Dis. 12 Suppl. 1 (2006) S3
9. Pang Y.H., Zheng C.Q., Wang Y.C., Li X.F., and Li F. Expression of interleukin-4 and interleukin-13 in ulcerative colitis. Chin. J. Gastroenterol. Hepatol. Dis. 14 (2005) 410-412
10. Leonard W.J., and O'Shea J.J. JAKS and STATS: biological implications. Ann. Rev. Immunol. 16 (1998) 293-312
11. Agnello D., Lankford C., Bream J., Morinobu A., Gadina M., O'Shea J.J., et al. Cytokines and transcription factors that regulate T helper cell differentiation: new players and new insights. J. Clin. Immunol. 23 (2003) 147-161
12. Bacon C.M., Petricoin III E.F., Ortaldo J.R., Rees R.C., Larner A.C., Johnston J.A., et al. Interleukin 12 induces tyrosine phosphorylation and activation of STAT4 in human lymphocytes. Proc. Natl. Acad. Sci. USA 92 (1995) 7307-7311
13. Jacobson N.G., Szabo S.J., Weber-Nordt R.M., Zhong Z., Schreiber R.D., Darnell Jr. J.E., and Murphy K.M. Interleukin 12 signaling in T helper type 1 (Th1) cells involves tyrosine phosphorylation of signal transducer and activator of transcription (Stat)3 and Stat4. J. Exp. Med. 181 (1995) 1755-1762
14. Wurster A.L., Tanaka T., and Grusby M.J. The biology of Stat4 and Stat6. Oncogene 19 (2000) 2577-2584
15. Watford W.T., Hissong B.D., Bream J.H., Kanno Y., Muul L., and O'Shea J.J. Signaling by IL-12 and IL-23 and the immunoregulatory roles of STAT4. Immunol. Rev. 202 (2004) 139-156
16. Kaplan M.H., Sun Y.L., Hoey T., and Grusby M.J. Impaired IL-12 responses and enhanced development of Th2 cells in Stat4-deficient mice. Nature 382 (1996) 174-177
17. Thierfelder W.E., van Deursen J.M., Yamamoto K., Tripp R.A., Sarawar S.R., Carson R.T., et al. Requirement for Stat4 in interleukin-12-mediated responses of natural killer and T cells. Nature 382 (1996) 171-174
18. Neurath M.F. IL-23: a master regulator in Crohn disease. Nat. Med. 13 (2007) 26-28
19. Monteleone G., Biancone L., Marasco R., Morrone G., Marasco O., Luzza F., et al. Interleukin 12 is expressed and actively released by Crohn's disease intestinal lamina propria mononuclear cells. Gastroenterology 112 (1997) 1169-1178
20. Nielsen O.H., Kirman I., Rudiger N., Hendel J., and Vainer B. Upregulation of interleukin-12 and -17 in active inflammatory bowel disease. Scand. J. Gastroenterol. 38 (2003) 180-185
21. Stenson W.F. Inflammatory bowel disease. The Cecil Textbook of Medicine. 21st ed. (2000), W.B. Sauners Co, Philadelphia 722-729
22. Schreiber S., Nikolaus S., and Hampe J. Activation of nuclear factor kappa B in inflammatory bowel disease. Gut 42 (1998) 477-484
23. Zhang W.J., Koltun W.A., Tilberg A.F., Thompson J.L., and Chorney M.J. Genetic control of IL4-induced activation of the human signal transducer and activator of transcription 6 signaling pathway. Hum. Immunol. 64 (2003) 402-415
24. Dong C., and Flavell R.A. Th1 and Th2 cells. Curr. Opin. Hematol. 8 (2001) 47-51
25. Lovato P., Brender C., Agnholt J., Kelsen J., Kaltoft K., Svejgaard A., et al. Constitutive STAT3 activation in intestinal T cells from patients with Crohn's disease. J. Biol. Chem. 278 (2003) 16777-16781
26. Hildner K.M., Schirmacher P., Atreya I., Dittmayer M., Bartsch B., Galle P.R., et al. Targeting of the transcription factor STAT4 by antisense phosphorothioate ligonucleotides suppresses collagen-induced arthritis. J. Immunol. 178 (2007) 3427-3436
27. Mudter J., and Neurath M.F. IL-6 signaling in inflammatory bowel disease: pathophysiological role and clinical relevance. Inflamm. Bowel Dis. 13 (2007) 1016-1023
28. Mudter J., Weigmann B., Bartsch B., Kiesslich R., Strand D., Galle P.R., et al. Activation pattern of signal transducers and activators of transcription (STAT) factors in inflammatory bowel diseases. Am. J. Gastroenterol. 100 (2005) 64-72
29. Musso A., Dentelli P., Carlino A., Chiusa L., Repici A., Sturm A., Fiocchi C., et al. Signal transducers and activators of transcription 3 signaling pathway: an essential mediator of inflammatory bowel disease and other forms of intestinal inflammation. Inflamm. Bowel Dis. 11 (2005) 91-98
30. Welte T., Zhang S.S., Wang T., Zhang Z., Hesslein D.G., Yin Z., et al. STAT3 deletion during ematopoiesis causes Crohn's disease-like pathogenesis and lethality: a critical role of STAT3 in innate immunity. Proc. Natl. Acad. Sci. USA 100 (2003) 1879-1884
31. Zhang W.J., Koltun W.A., Thompson J.L., Tilberg A.F., Galka E., Poritz L.S., and Chorney M.J. A defective human Stat6 signaling phenotype correlates with high levels of proinflammatory cytokines IL-12, TNFα and IFNγ. Int. J. Oncol. 24 (2004) 447-453
32. W.J. Zhang, W.A. Koltun, in: Annese et al. (Eds.), HLA-DRB1 alleles in an Italian IBD population, Dis. Colon Rectum 48 (2005) 57-65.
33. Neurath M.F., and Finotto S. The many roads to inflammatory bowel diseases. Immunity 25 (2006) 189-191